Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
21/01/2020 | 23:16 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:PRTO | Proteon Therapeutics Inc |
17/01/2020 | 22:10 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
16/01/2020 | 14:01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PRTO | Proteon Therapeutics Inc |
15/01/2020 | 12:04 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:PRTO | Proteon Therapeutics Inc |
14/01/2020 | 00:56 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:PRTO | Proteon Therapeutics Inc |
14/01/2020 | 00:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PRTO | Proteon Therapeutics Inc |
10/01/2020 | 23:26 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PRTO | Proteon Therapeutics Inc |
09/01/2020 | 19:43 | GlobeNewswire Inc. | ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics | NASDAQ:PRTO | Proteon Therapeutics Inc |
31/12/2019 | 22:05 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:PRTO | Proteon Therapeutics Inc |
20/12/2019 | 22:06 | Edgar (US Regulatory) | Withdrawal of Registration Statement (rw) | NASDAQ:PRTO | Proteon Therapeutics Inc |
20/12/2019 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PRTO | Proteon Therapeutics Inc |
19/12/2019 | 22:26 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:PRTO | Proteon Therapeutics Inc |
18/12/2019 | 23:46 | Edgar (US Regulatory) | Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
03/12/2019 | 23:45 | PR Newswire (US) | Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina T... | NASDAQ:PRTO | Proteon Therapeutics Inc |
22/11/2019 | 16:37 | PR Newswire (US) | Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), an... | NASDAQ:PRTO | Proteon Therapeutics Inc |
21/11/2019 | 23:33 | PR Newswire (US) | SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc. | NASDAQ:PRTO | Proteon Therapeutics Inc |
07/11/2019 | 12:09 | Edgar (US Regulatory) | Securities Registration: Business Combination (s-4) | NASDAQ:PRTO | Proteon Therapeutics Inc |
31/10/2019 | 22:02 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:PRTO | Proteon Therapeutics Inc |
23/09/2019 | 22:20 | GlobeNewswire Inc. | Proteon Therapeutics and ArTara Therapeutics Agree to Combine | NASDAQ:PRTO | Proteon Therapeutics Inc |
07/08/2019 | 14:00 | GlobeNewswire Inc. | Proteon Therapeutics Announces Second Quarter 2019 Financial Results | NASDAQ:PRTO | Proteon Therapeutics Inc |
08/05/2019 | 14:00 | GlobeNewswire Inc. | Proteon Therapeutics Announces First Quarter 2019 Financial Results | NASDAQ:PRTO | Proteon Therapeutics Inc |
15/04/2019 | 22:30 | GlobeNewswire Inc. | Proteon Therapeutics Announces Review of Potential Strategic Transactions | NASDAQ:PRTO | Proteon Therapeutics Inc |
12/04/2019 | 14:11 | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:PRTO | Proteon Therapeutics Inc |
28/03/2019 | 13:00 | GlobeNewswire Inc. | Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteri... | NASDAQ:PRTO | Proteon Therapeutics Inc |
14/03/2019 | 22:06 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:PRTO | Proteon Therapeutics Inc |
13/03/2019 | 13:03 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:PRTO | Proteon Therapeutics Inc |
13/03/2019 | 13:00 | GlobeNewswire Inc. | Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results | NASDAQ:PRTO | Proteon Therapeutics Inc |
04/03/2019 | 22:30 | GlobeNewswire Inc. | Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th | NASDAQ:PRTO | Proteon Therapeutics Inc |
24/01/2019 | 14:00 | GlobeNewswire Inc. | Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase i... | NASDAQ:PRTO | Proteon Therapeutics Inc |
18/12/2018 | 14:41 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) | NASDAQ:PRTO | Proteon Therapeutics Inc |